ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.662,38
0,08%
S&P 500
5.431,60
-0,04%
US Dollar vs BRL
5,3773
0,50%
Bitcoin
66.210,90
0,03%
Brent Oil
82,275
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Lexicon Pharmaceuticals Inc (LXRX)

  7. Lexicon Pharmaceuticals Inc (LXRX) Notícias

LXRX Lexicon Pharmaceuticals Inc

1,80
-0,03 (-1,64%)
15 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Lexicon Pharmaceuticals Inc LXRX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
-0,03 -1,64% 1,80 01:00:01
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,83 1,78 1,875 1,82 1,83
mais cotações »

Notícias Recentes

Data Hora Fonte Título
14/06/202409:00GLOBEFindings on the Burdens of Diabetic Peripheral Neuropathic..
29/05/202408:30GLOBELexicon Pharmaceuticals to Participate in the Jefferies..
14/05/202408:00GLOBENew Post-Hoc Analysis of Pooled Phase 3 Data Shows That..
09/05/202408:30GLOBELexicon Pharmaceuticals to Participate in the Bank of..
02/05/202417:05GLOBELexicon Pharmaceuticals Reports First Quarter 2024 Financial..
29/04/202410:00GLOBELonnel Coats Retires as Chief Executive Officer and Board..
29/04/202408:00GLOBELexicon Pharmaceuticals to Host First Quarter 2024 Financial..
18/04/202409:00GLOBELexicon Pharmaceuticals to Host 2024 Investor Day
03/04/202409:00GLOBELexicon Pharmaceuticals to Participate in the 23rd Annual..
25/03/202410:20GLOBEClinical Data on the Impact of Sotagliflozin on Stroke and..
12/03/202409:00GLOBENew Post Hoc Analysis of inTandem3 Study Demonstrates..
11/03/202408:15GLOBELexicon Pharmaceuticals Reports Fourth Quarter..
11/03/202408:05GLOBELexicon Announces Oversubscribed $250 Million Private..
11/03/202408:00GLOBELexicon Preparing to Resubmit Sotagliflozin NDA for Type 1..
08/01/202409:00GLOBELexicon Pharmaceuticals Provides Business and Pipeline..
21/12/202318:15GLOBELexicon Pharmaceuticals To Participate In The 42nd Annual..
30/11/202309:30GLOBELexicon Enrolls First Patient in Phase 2b Progress Study of..
22/11/202309:30GLOBELexicon Pharmaceuticals to Participate in the 35th Annual..
12/11/202316:10GLOBEINPEFA® (sotagliflozin) Use Associated With Early Clinical..
10/11/202318:01GLOBELexicon Pharmaceuticals to Participate in the Jefferies..
08/11/202309:00GLOBELexicon Pharmaceuticals Reports Third Quarter 2023 Financial..
03/11/202310:00GLOBELexicon Pharmaceuticals to Host Third Quarter 2023 Financial..
02/11/202310:00GLOBEData on Early Clinical Benefit for INPEFA® (Sotagliflozin)..
01/11/202310:00GLOBEINPEFA® (Sotagliflozin) Receives Coverage From Express..
31/10/202317:01GLOBELexicon Strengthens Management Team With Two New Executives
30/10/202317:01GLOBENew Data Relating to Sotagliflozin to be Presented at the..
17/10/202317:01GLOBEData From Two Studies Demonstrating Positive Financial..
11/10/202310:00GLOBEData Demonstrating Financial Impact of INPEFA®..
09/10/202317:01GLOBEINPEFA® (Sotagliflozin) Receives Preferred Formulary Status..
09/10/202309:00GLOBETom Garner Joins Lexicon as Senior Vice President and Chief..
28/09/202310:00GLOBELexicon to Present Post Hoc Analysis of Scored Clinical..
26/09/202310:00GLOBELexicon to Present Study Results Relating to Sotagliflozin..
07/09/202317:30GLOBELexicon Pharmaceuticals to Participate in the H.C...
07/09/202310:00GLOBELexicon Announces Series of Presentations Relating to..
21/08/202310:00GLOBELexicon to Present Analyses of INPEFA™ (sotagliflozin)..
08/08/202310:00GLOBEPublished Analysis of Sotagliflozin (INPEFA(TM)) Clinical..
03/08/202317:01GLOBELexicon Pharmaceuticals Reports Second Quarter 2023..
28/07/202317:01GLOBELexicon Pharmaceuticals to Host Second Quarter 2023..
28/07/202309:00GLOBELexicon Elects Diane E. Sullivan to Board of Directors
23/06/202321:45GLOBELexicon Announces Planned Advancement of LX9211 Into..
20/06/202309:00GLOBELexicon to Present Study Results Relating to LX9211 and..

Seu Histórico Recente

NASDAQ
LXRX
Lexicon Pharmaceuticals
BIT
UB6DCH
Unicredit Bank
BIT
P1ZQ94
NLBNPIT1ZQ94 20240621 580
COIN
SETTTETH
Setter Protocol
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados